Press Release

Atreca Announces Participation in Two Upcoming Virtual Investor Conferences

April 6, 2020 at 4:30 PM EDT

SOUTH SAN FRANCISCO, Calif., April 06, 2020 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today announced that it will participate in two upcoming investor conferences:

Canaccord Genuity Horizons in Oncology Virtual Event
Wednesday, April 8, 2020
Panel time: 12:45 p.m. EDT

19th Annual Needham Virtual Healthcare Conference
Wednesday, April 15, 2020
Presentation time: 2:50 p.m. EDT

Live webcasts of each event can be accessed through the Events & Presentations section of the Company's website at Archived replays of the webcasts will be available on the Company's website for 90 days following the live presentations.

About Atreca, Inc.
Atreca is a biopharmaceutical company developing novel antibody-based cancer immunotherapeutics generated by its differentiated discovery platform. Atreca’s platform allows access to an unexplored landscape in oncology through the identification of unique antibody-target pairs generated by the human immune system during an active immune response against tumor. These antibodies provide the basis for first-in-class therapeutic candidates, such as our lead product candidate ATRC-101. A Phase 1b study evaluating ATRC-101 in multiple solid tumor cancers is currently enrolling patients. For more information on Atreca, please visit

Atreca, Inc.
Herb Cross
Chief Financial Officer

Alex Gray, 650-779-9251

Sheryl Seapy, 213-262-9390

Source: Atreca, Inc.


Source: Atreca, Inc.